Zopiclone
Drug7.5 mg before sleep, the evening before surgery
Other names: Imovane
NCT Number: NCT01549691
The purpose of this study is to test the level of anxiety in patients, the day before surgery (late afternoon) and immediately prior to surgery in 3 parallel groups of patients.
* one receiving placebo before going to sleep (before sleep), the day prior surgery and placebo when awakening (awakening), the day of surgery * one receiving zopiclone (7.5 mg) before sleep and placebo at awakening * one receiving placebo before sleep and alprazolam (0.5 mg)at awakening
double blind, randomized controlled study
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 4
Clinique Sévigné, Cesson, Brittany Region, France
Eligibility:
Outcome measures:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
7.5 mg before sleep, the evening before surgery
Other names: Imovane
0.5 mg at awakening, the day of surgery
Other names: Xanax
given night before surgery and at awakening, the day of surgery
Time frame: duration of the study : 12 hours (one evaluation on late afternoon the day before surgery and the second evaluation on arrival to operating room)
Time frame: on arrival to operating room (one single recording)
recording of actual (using the operating room monitor):
University Hospital, Angers
Other Gov
Assessment of Two Modes of Premedication in Surgery - PREMED Study
Acronym: PREMED
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06942637
Adolescents, Anxiety
Bandung, West Java, Indonesia
View Trial DetailsNCT07739381
Anxiety, Anxiety Disorders
Kütahya, Turkey (Türkiye)
View Trial DetailsNCT07421063
Anxiety, Anxiety Disorders
Bolu, Turkey (Türkiye)
View Trial DetailsNCT05438446
Anxiety, Anxiety Disorders
Athens, Attica, Greece
View Trial Details